JOSEPH GRAU: Open Payments
NPI 1508868456 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,765 in 102 payments from 14 companies in 2025. Trend: 2023 $1,825 · 2024 $1,613 · 2025 $1,765
Food & beverage: $1,765
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $308 |
| Otsuka America Pharmaceutical, Inc. | 14 | $272 |
| Janssen Pharmaceuticals, Inc | 18 | $227 |
| Axsome Therapeutics, Inc. | 9 | $169 |
| Vanda Pharmaceuticals Inc. | 7 | $165 |
| Teva Pharmaceuticals USA, Inc. | 9 | $146 |
| Alkermes, Inc. | 4 | $98 |
| Biogen, Inc. | 5 | $95 |
| E.R. Squibb & Sons, L.L.C. | 4 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $85 |
Products named: VRAYLAR, INVEGA SUSTENNA, REXULTI, Auvelity, FANAPT, ABILIFY MAINTENA, LYBALVI, ZURZUVAE.
Industry payments across KY — which companies pay providers there.
